LANTERN PHARMA INC (LTRN:NASDAQ)

$2.16 -0.02 (-0.9174%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 64

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed LANTERN PHARMA INC (LTRN:NASDAQ) News Sources

Lantern Pharma Inc. Q2 2026 Earnings Call Summary

14-08-2026

moby.co

external link

Lantern Pharma (LTRN) Q1 2025 Earnings Transcript

21-05-2026

fool.com

external link

Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent "Computational Biologist" That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer

08-07-2026

yahoo.com

external link

Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers

23-07-2026

yahoo.com

external link

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer

28-07-2026

yahoo.com

external link

Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine

03-08-2026

yahoo.com

external link

Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET

07-08-2026

yahoo.com

external link

Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update

14-08-2026

yahoo.com

external link

Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI-Driven Pipeline Advances Amid ...

20-08-2026

yahoo.com

external link

Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript

21-08-2026

fool.com

external link

LANTERN PHARMA INC (LTRN:NASDAQ) Sentiment Trend

0 25 50 75 100 26 25 89 52 77 88 54 66 91 75 14-08-2026 21-05-2026 08-07-2026 23-07-2026 28-07-2026 03-08-2026 07-08-2026 20-08-2026 21-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

LANTERN PHARMA INC (LTRN:NASDAQ) FAQs

toggle

What is the current price of LANTERN PHARMA INC (LTRN:NASDAQ)?

The current price of LANTERN PHARMA INC (LTRN:NASDAQ) is $2.16.


toggle

LANTERN PHARMA INC (LTRN:NASDAQ) absolute price change since previous trading day?

The absolute price change of LANTERN PHARMA INC (LTRN:NASDAQ) since the previous trading day is $-0.02.


toggle

LANTERN PHARMA INC (LTRN:NASDAQ) percentage price change since previous trading day?

The percentage price change of LANTERN PHARMA INC (LTRN:NASDAQ) since the previous trading day is -0.9174%.


toggle

What is the most recent average sentiment score for LANTERN PHARMA INC (LTRN:NASDAQ)?

The most recent average sentiment score for LANTERN PHARMA INC (LTRN:NASDAQ) is 64 out of 100.


toggle

What is the most recent average sentiment for LANTERN PHARMA INC (LTRN:NASDAQ)?

The most recent sentiment for LANTERN PHARMA INC (LTRN:NASDAQ) is .


SEC-8K** Filing Available For LANTERN PHARMA INC (LTRN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

GERN (Geron Corp)
CTRN (Citi Trends Inc)
BMRN (Biomarin Pharmaceuticals)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.